StockGlow

SAB Biotherapeutics, Inc. (SABSW)

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States.

$0.02+0.27%
Compare SABSW with
StockGlow Score
100
Bullish
BearishBullish
1 year ago-49.7%

The outlook

SAB Biotherapeutics, Inc. currently reads as bullish based on 100% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

52-week range100% of the way from its 52-week low to high
Market cap
—
52-wk high
$0.02
52-wk low
$0.01
50-day avg
—
200-day avg
—
Trailing P/E
0.1

Similar stocks

SABSSAB Biotherapeutics, Inc.$3.50-1.83%JSPRWJasper Therapeutics, Inc.$0.01+0.00%REVBWRevelation Biosciences, Inc.$0.01+0.00%SRZNWSurrozen, Inc.$0.01+0.00%HUMAWHumacyte, Inc.$0.01-11.11%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy